Effects of ginkgo biloba extract and bilobalide on neuronal injury of substantia nigra of rats with Parkinson disease

Chinese Journal of Clinical Rehabilitation

Volumn 10, Issue 11, 2006, Pages 39-41

  Ba, Xiao Hong ^a   Liu, Ying ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILOBALIDE; GINKGO BILOBA EXTRACT; MALONALDEHYDE; OXIDOPAMINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CHINA; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG MEGADOSE; ENZYME ACTIVITY; GINKGO BILOBA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MALE; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RAT; RAT STRAIN; STUDENT T TEST; SUBSTANTIA NIGRA; TISSUE LEVEL;

EID: 33646027910     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Thomas J, Wang J, Takubo H, et al. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Exp Neurol 1994;126(2):159-67
2. Seaton TA, Cooper JM, Schapira AH.Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins.Brain Res 1998;809(1):12-7
3. Tompkins MM, Basgall EJ, Zamrini E, et al. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.Am J Pathol 1997;150(1):119-31
4. Chinese source. 1997, (5):249-52
5. Shoulson I.Neuroprotective clinical strategies for Parkinson's disease.Ann Neurol 1992;32 Suppl:S143-5
6. Camp DM,Loeffler DA,LeWitt PA.L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.J Neurochem 2000;74(3):1229-40
7. Chinese source. 1998,14(14):300
8. Chinese source. 2001, 28(5):396-9